Former Qualcomm executive Dr. Karim Arabi has been convicted by a jury on charges of fraud and money laundering in connection with a scheme that defrauded his employer of $180 million. The verdict followed a four-week trial that ended with the jury deliberating for less than two days. Dr. Arabi, who served as vice president of Qualcomm’s Research and Development Department, was found to have created a company secretly to develop microchip technology that, in agreement with his employment terms, rightfully belonged to Qualcomm. He subsequently sold the company and its technology back to Qualcomm, as reported by the U.S. Attorney's Office.
The case presented evidence that Arabi had concealed his involvement as the shadow CEO of the shell company Abreezio, using various deceptive measures such as impersonating his sister in emails and having her legally change her name. Qualcomm unknowingly paid almost $92 million to Arabi’s sister for the technology they already owned, and further funds were distributed to Arabi through complex money-laundering schemes that involved Canadian and Norwegian real estate and U.S. shell companies. According to Acting U.S. Attorney Andrew Haden, "The defendant took advantage of the trust placed in him, lining his pockets with millions by orchestrating a scheme to deceive and then bleed his own employer," this quote reflects the gravity of the betrayal, which has been met with a stern response by the justice system, as per the U.S. Attorney's Office.
Throughout the proceedings, the prosecution argued that Arabi’s actions represented not only a betrayal of Qualcomm's trust, striking at the heart of fair business practices, but also that his fraud had large-scale implications on the integrity of transactional relationships within the corporate sector. "Dr. Arabi perpetrated an elaborate and exhaustive scheme to conceal, deceive, and defraud his employer out of millions of dollars," expressed FBI San Diego Acting Special Agent in Charge Houtan Moshrefi, adding that, with this verdict, a message is sent that such deceptive corporate practices will be met with accountability and legal consequence, as cited by the U.S. Attorney's Office.
